A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

• Patient Safety and Quality

• Core Measures
• Employee Stories
• Patient Safety Resources
• Audio/Video Library
• In the News

Patient Safety and Quality

Core Measures

Heart Attack Care: ACEI or ARB for LVSD

 

Ask the Expert

Get answers to your heart disease prevention questions.

Dr. Miller’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Related Content

• Audio Podcast: Cholesterol
  
• Audio Podcast: Niacin and Heart Disease Prevention
  
• Center for Preventive Cardiology
  
• Niacin and Heart Disease Prevention Study
  
• Video: Heart Disease Prevention
  

 

ACE (angiotensin converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) improve the heart's ability to pump blood. These medicines are used to treat heart attacks, heart failure or a decreased function of the heart.

The chart below shows the percentage of UMMC heart attack patients prescribed an ACE inhibitor or ARB for left ventricular systolic dysfunction (LVSD) as compared to the national average.

Source: The Joint Commission

© 2012 University of Maryland Medical Center (UMMC). All rights reserved. UMMC is a member of the University of Maryland Medical System, 22 S. Greene Street, Baltimore, MD 21201. 1.866.408.6885 TDD: 1.800.735.2258
Physician Referral: 1.800.373.4111

• Home
• Site map
• Compliance Policies
• Awards & Honors
• UMMC Blog